Insider Transactions in Q3 2018 at Principia Biopharma Inc. (PRNB)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+8.75%
|
$4,250,000
$17.0 P/Share
|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect |
270,000
+9.32%
|
$4,590,000
$17.0 P/Share
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|